Mitochondria

#Agilent #Mitochondria #Neurodegenerative disorders #Neurology #Rare disease

Neuronal metabolism and its impact on early drug discovery

CLN7 neuronal ceroid lipofuscinosis is an inherited lysosomal storage neurodegenerative disease highly prevalent in children. In her webinar, Dr García Macía discusses how failure in autophagy causes the accumulation of structurally and bioenergetically impaired neuronal mitochondria in the mouse model of CLN7 disease, and how the mitochondrial reactive oxygen species… Read More

Webinar date:
Brought to you by Agilent
#Webinars

Covid-19
#Axcella Therapeutics #Covid-19 #Long Covid #Mitochondria #Phase II trial #University of Oxford

Encouraging trial results for long Covid fatigue treatment

Researchers from the University of Oxford have reported findings from a Phase II clinical trial investigating the efficacy of an investigational treatment against long Covid fatigue. The study found that participants given the treatment, AXA1125, developed by US pharmaceutical company Axcella Therapeutics, felt less fatigued than… Read More

#Editor's Choice #News

#In vitro #Mitochondria

How to learn new ways to identify mitochondrial liability

Drug-induced mitochondrial dysfunction has been linked to compound attrition, organ toxicity, black-box warnings, and market withdrawals. Agilent has released a mitochondrial toxicity infographic to help you discover the benefits of novel in vitro strategies for consumer safety. This infographic is designed to help: Gain a historical perspective on mitochondrial toxicity. Understand… Read More

#News